Virios Therapeutics, Inc. (NASDAQ:VIRI – Get Rating) saw a large growth in short interest in March. As of March 15th, there was short interest totalling 368,800 shares, a growth of 52.5% from the February 28th total of 241,900 shares. Based on an average daily trading volume, of 489,400 shares, the days-to-cover ratio is presently 0.8 […]